| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.033 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |